Novel strategies on the horizon for pancreatic cancer: an interview with Philip A Philip


At the ESMO World Congress on Gastrointestinal Cancer 2017 (Barcelona, Spain, 28 June–1 July) we had the pleasure of speaking with Philip A. Philip from Karmanos Cancer Center (MI, USA). Listen to the interview now, to find out about novel agents and strategies for pancreatic cancer as well as Philip’s favorite talks from the congress.

Dr. Philip is a professor of oncology and medicine at the Karmanos Cancer Institute and Wayne State University School of Medicine (MI, USA). He leads the gastrointestinal and neuroendocrine tumors multidisciplinary team and is the vice president of medical affairs at Karmanos. He also chairs the pancreatic cancer subcommittee at the Southwest Oncology Group and is a member of the intergroup’s task force on pancreatic cancer. He also sits on the medical advisory board for the Pancreatic Action network (PanCan) and been very active in advocacy and fundraising for cancer. Dr. Philip practices as medical oncologist specializing in gastrointestinal cancers and neuroendocrine tumors.